NFKB1 and type 2 diabetes mellitus: In the T2DM model, increased NF-κB levels widely exist in the intestine, pancreas, and insulin-target organs (Zhang et al., 2020), and are closely related to chronic inflammation, oxidative stress, insulin resistance, and several complications (Sahukari et al., 2020).